Kieran O'Kane
CIK: 0001828131
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BIODESIX INC
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Feb 23, 2026BDSX
BIODESIX INC
Sale(S)Direct535 shares at avg. $12.78$7K - Feb 20, 2026BDSX
BIODESIX INC
Exercise(M)Direct1.5K shares- - Feb 10, 2026BDSX
BIODESIX INC
Sale(S)Direct584 shares at avg. $10.08$6K - Feb 9, 2026BDSX
BIODESIX INC
Exercise(M)Direct1.6K shares- - Jan 16, 2026BDSX
BIODESIX INC
Sale(S)Direct298 shares at avg. $8.15$2K - Jan 15, 2026BDSX
BIODESIX INC
Exercise(M)Direct805 shares- - Jan 2, 2026BDSX
BIODESIX INC
Award(A)DirectStock Options (Right to Buy)
27K shares- - Nov 10, 2025BDSX
BIODESIX INC
Exercise(M)Direct75 shares- - Nov 10, 2025BDSX
BIODESIX INC
Sale(S)Direct25 shares at avg. $7.62$190.5 - Aug 13, 2025BDSX
BIODESIX INC
Sale(S)Direct476 shares at avg. $0.42$198.159 - Aug 12, 2025BDSX
BIODESIX INC
Exercise(M)Direct1.5K shares- - May 13, 2025BDSX
BIODESIX INC
Sale(S)Direct238 shares at avg. $0.35$83.99 - May 12, 2025BDSX
BIODESIX INC
Sale(S)Direct239 shares at avg. $0.36$85.897 - May 9, 2025BDSX
BIODESIX INC
Exercise(M)Direct1.5K shares- - Feb 20, 2025BDSX
BIODESIX INC
Award(A)DirectRestricted Stock Units
117.5K shares- - Feb 20, 2025BDSX
BIODESIX INC
Award(A)DirectStock Options (Right to buy)
235K shares- - Feb 20, 2025BDSX
BIODESIX INC
Award(A)DirectStock Options (Right to buy)
87.3K shares- - Feb 11, 2025BDSX
BIODESIX INC
Sale(S)Direct17.5K shares at avg. $0.92$16K - Feb 10, 2025BDSX
BIODESIX INC
Exercise(M)Direct48.1K shares- - Nov 12, 2024BDSX
BIODESIX INC
Sale(S)Direct224 shares at avg. $1.40$313.779 - Nov 11, 2024BDSX
BIODESIX INC
Sale(S)Direct238 shares at avg. $1.39$331.034 - Nov 8, 2024BDSX
BIODESIX INC
Exercise(M)Direct1.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 23, 2026 | BDSX BIODESIX INC | Sale(S) | 535 | $12.78 | $6,835 | Direct |
| Feb 20, 2026 | BDSX BIODESIX INC | Exercise(M) | 1,469 | - | $0 | Direct |
| Feb 10, 2026 | BDSX BIODESIX INC | Sale(S) | 584 | $10.08 | $5,889 | Direct |
| Feb 9, 2026 | BDSX BIODESIX INC | Exercise(M) | 1,600 | - | $0 | Direct |
| Jan 16, 2026 | BDSX BIODESIX INC | Sale(S) | 298 | $8.15 | $2,428 | Direct |
| Jan 15, 2026 | BDSX BIODESIX INC | Exercise(M) | 805 | - | $0 | Direct |
| Jan 2, 2026 | BDSX BIODESIX INC | Award(A) Stock Options (Right to Buy) | 27,000 | - | - | Direct |
| Nov 10, 2025 | BDSX BIODESIX INC | Exercise(M) | 75 | - | - | Direct |
| Nov 10, 2025 | BDSX BIODESIX INC | Sale(S) | 25 | $7.62 | $191 | Direct |
| Aug 13, 2025 | BDSX BIODESIX INC | Sale(S) | 476 | $0.42 | $198 | Direct |
| Aug 12, 2025 | BDSX BIODESIX INC | Exercise(M) | 1,489 | - | - | Direct |
| May 13, 2025 | BDSX BIODESIX INC | Sale(S) | 238 | $0.35 | $84 | Direct |
| May 12, 2025 | BDSX BIODESIX INC | Sale(S) | 239 | $0.36 | $86 | Direct |
| May 9, 2025 | BDSX BIODESIX INC | Exercise(M) | 1,490 | - | - | Direct |
| Feb 20, 2025 | BDSX BIODESIX INC | Award(A) Restricted Stock Units | 117,500 | - | - | Direct |
| Feb 20, 2025 | BDSX BIODESIX INC | Award(A) Stock Options (Right to buy) | 235,000 | - | - | Direct |
| Feb 20, 2025 | BDSX BIODESIX INC | Award(A) Stock Options (Right to buy) | 87,319 | - | - | Direct |
| Feb 11, 2025 | BDSX BIODESIX INC | Sale(S) | 17,527 | $0.92 | $16,198 | Direct |
| Feb 10, 2025 | BDSX BIODESIX INC | Exercise(M) | 48,118 | - | - | Direct |
| Nov 12, 2024 | BDSX BIODESIX INC | Sale(S) | 224 | $1.40 | $314 | Direct |
| Nov 11, 2024 | BDSX BIODESIX INC | Sale(S) | 238 | $1.39 | $331 | Direct |
| Nov 8, 2024 | BDSX BIODESIX INC | Exercise(M) | 1,490 | - | $0 | Direct |
1-22 of 22 transactions
About O'Kane Kieran
O'Kane Kieran (SEC CIK 0001828131) files insider reports with the SEC as Chief Commercial Officer of BIODESIX INC (BDSX).
Signal8 holds 10 ownership filings by O'Kane Kieran, all Form 4s, filed between Nov 13, 2024 and Feb 23, 2026. Those filings report 22 transactions, from Nov 8, 2024 to Feb 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on O'Kane Kieran's filings is in LOUISVILLE, CO.
Recent filings by O'Kane Kieran
- Feb 23, 2026: Open-market sale of BDSX shares (Form 4, code S).
- Feb 20, 2026: Option exercise of BDSX shares (Form 4, code M).
- Feb 10, 2026: Open-market sale of BDSX shares (Form 4, code S).
- Feb 9, 2026: Option exercise of BDSX shares (Form 4, code M).
- Jan 16, 2026: Open-market sale of BDSX shares (Form 4, code S).
Other insiders filing for BIODESIX INC (BDSX)
- PATIENCE JOHN, Director
- SCHULER JACK W, 10% Owner
- Pestano Gary Anthony, Chief Development Officer
- Cowie Robin Harper, CFO, Sec'y & Treasurer
- Vazquez Chris, Chief Accounting Officer
- Hutton Scott, President & CEO